Filgrastim Terminated Phase 2 / 3 Trials for Leukemia Acute Myeloid Leukemia (AML) / Smith-Magenis Syndrome / Leukemia, Lymphocytic, Acute Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT03381118Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients